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Detection of multiple vascular endothelial growth factor splice
isoforms in single glomerular podocytes. Glomerular podocytes
are major determinants of filtration permselectivity in the glomer-
ulus. Although the molecular mechanisms determining the char-
acteristics of the glomerular filtration unit are incompletely
understood, vascular endothelial growth factor (VEGF) has been
implicated. To analyze this process in situ, we established a
method that allows exploration of in vivo mRNA expression of
podocytes using single-cell reverse transcriptase-polymerase chain
reaction (RT-PCR). Microdissected mouse glomeruli were held in
a patch-clamp apparatus, and single podocytes were harvested by
aspiration. After lysis, the cells were reverse transcribed, and PCR
was performed (45 cycles). The podocyte nature of the material
was confirmed by detection of podocyte-specific mRNA (glomer-
ular epithelial protein 1 and Wilms’ tumor protein 1). Using
specific oligonucleotide primers, VEGF was detected in mRNA
obtained from renal cortex, single microdissected glomeruli, cul-
tured murine podocytes, and single podocytes in situ. All cells
examined expressed three VEGF isoforms (121, 165, and 189).
These differ in their capacity for binding to extracellular matrix
and could have different potencies regulating glomerular endo-
thelial permeability. Our approach should allow a semiquantita-
tive, isoform-specific evaluation of VEGF mRNA expression in
podocytes during nephrogenesis and in glomerular disease.
The glomerular podocyte plays a major role in filtration
permselectivity of the glomerulus. Although the mecha-
nisms determining the characteristics of the glomerular
filtration unit are only incompletely understood, vascular
endothelial growth factor (VEGF) has been implicated [1,
2]. VEGF is a conserved, dimeric glycoprotein with struc-
tural homology to platelet-derived growth factor. It is a
highly selective mitogen in vascular endothelial cells and
increases microvascular permeability and nitric oxide-de-
pendent relaxation of small muscular arteries. Chemoat-
traction of monocytes and expression of plasminogen acti-
vator and its inhibitor [3] are also enhanced. VEGF is
expressed mainly by epithelial cells as a secreted peptide.
The corresponding receptors (KDR and flt-1 in human and
flk-1 in the mouse) are found on glomerular endothelial
cells [1]. In the human kidney, VEGF mRNA and protein
localize predominantly to the glomerulus, although lower
and less consistent focal tubular expression has also been
described. Paracrine secretion with VEGF production in
podocytes and consecutive binding to endothelium have
been proposed as regulatory mechanisms for normal func-
tion of the glomerular filtration barrier [1, 2].
The presence of VEGF is crucial for normal renal
development that depends on precisely controlled vascu-
larization. Differentiating glomerular epithelia produce
VEGF and may attract endothelial cells into the glomeruli
[1]. Administration of anti-VEGF antibody during early
kidney development in mice leads to formation of abnor-
mal glomerular structures and diminished nephrogenesis as
an indirect effect of disturbed blood vessel formation. In
VEGF antibody-treated animals, a dual glomerular base-
ment membrane, immature glomerular capillaries with
slitlike lumen and amorphous substance surrounded by
podocytes occur [4]. Various glomerular diseases are char-
acterized by high VEGF expression in glomeruli with
preserved architecture, whereas VEGF production is de-
creased in glomeruli damaged by amyloid deposition, glo-
merulosclerosis, or compression by crescents. Although
up-regulation of VEGF has been postulated as a compen-
satory response of epithelial cells to reconstruct a glomer-
ulus, limitations of the mRNA detection technique (in situ
hybridization) have hindered further analysis of VEGF
mRNA expression in glomeruli [3].
We have established a method allowing exploration of in
vivo mRNA expression of podocytes at the single-cell level
[5]. In this study, we employ this method to analyze the
mRNA expression profile of VEGF in podocytes.
SINGLE PODOCYTE REVERSE TRANSCRIPTASE-
POLYMERASE CHAIN REACTION
Single-cell RT-PCR was performed as described [5]. In
brief, microdissected mouse glomeruli were fixed via a
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holding pipette on a patch-clamp apparatus. Single podo-
cytes were harvested selectively by aspiration of the cell
soma into a micropipette at an rate of 10 to 15 podocytes/
hour (Fig. 1). After reverse transcription, PCR was per-
formed using sequence-specific oligonucleotide primers
and 40 to 50 amplification cycles [5]. One third of all
samples consisted of negative controls (superfusion me-
dium aspirated next to the glomerulus) to exclude contam-
ination. PCR product authenticity was verified by cycle
sequencing of the cloned amplification product. To control
for cDNA yield, the housekeeping gene b actin was ana-
lyzed in 3-ml aliquots of each sample and was detected in
68% of all cells analyzed. The podocyte nature of the cells
was confirmed by detection of mRNA for the putative
mouse homologue of glomerular epithelial protein 1 (61%
positive, N 5 26) and Wilms’ tumor protein 1 (28%
positive, N 5 32). The endothelial cell marker von Wille-
brand factor was undetectable (N 5 15).
VEGF ISOFORMS IN PODOCYTES
Three splice variants generated from a single gene have
been found in the human kidney: VEGF121, VEGF165, and
VEGF189 [1]. The VEGF gene contains eight exons
whereby exons 1 to 5 encode a region required for ligand
recognition by the KDR receptor and are present in all
isoforms. VEGF121 lacks exons 6 and 7; VEGF165 lacks
exon 6, and VEGF189 contains all exons (Fig. 2b) [6]. The
major functional difference between the various VEGF
isoforms is their ability to bind heparin, encoded for by
exon 6. VEGF121, lacking exon 6, does not bind heparin
and is freely soluble, whereas VEGF189 is cell and matrix
associated, whereas VEGF165 has intermediate heparin-
binding characteristics [7]. Differences in heparin binding
of the various isoforms may affect the diffusion of this
paracrine factor from the producing cells to target endo-
thelial cells. The extracellular matrix may serve as a storage
for VEGF165 and VEGF189 that can dissociate slowly or be
released by the action of proteases [7]. Increased protease
activity, as occurs in glomerular diseases, could therefore
release matrix-stored VEGF and increase glomerular cap-
illary permeability.
We used a primer pair combination spanning exons 6 and
7 for amplification (Fig. 2). Three PCR products, corre-
sponding to the three splice isoforms, were obtained from
mouse kidney cortex and isolated glomeruli using standard
RT-PCR (Fig. 2; technique see [8]). VEGF165 was the most
abundant isoform, whereas VEGF189 was the least abun-
dant. Single-cell RT-PCR also detected all three isoforms
in single, resident glomerular podocytes. For podocyte cell
culture, we used a conditionally immortalized cell line [9].
This transgene mouse podocyte cell line contains the SV40
T antigen under the control of an interferon-g and ther-
mosensible promoter. The cells are propagated under
permissive conditions (interferon-g, 33°C) in an undiffer-
entiated state (cobblestone epithelium). Withdrawal of
interferon-g and increasing culture temperature to 37°C
induce a more differentiated, “arborized” phenotype. For
standardization of the cDNA prior to quantification, ade-
nine nucleotide carrier expression was used as a house-
keeping gene. As in single podocyte RT-PCR, the VEGF
isoforms 121, 165, and 189 were found in cultured podo-
cytes. Interestingly, all isoforms showed marked up-regula-
tion after induction of the arborized phenotype.
The techniques described will allow semiquantitative and
Fig. 1. Photomicrograph demonstrating the
podocyte aspiration technique: fixed glomerular
tuft (left), single podocyte cell soma aspirated
in the tip of a micropipette (right).
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isoform-specific evaluation of podocyte VEGF mRNA
expression. Single podocyte RT-PCR will enable also ex-
amination of the role of different splice isoforms during
nephrogenesis and in glomerular diseases. The cell culture
system of the conditionally immortalized podocyte will
provide also a crucial tool for examining the molecular
mechanisms controlling VEGF expression in vitro.
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Fig. 2. (A) VEGF expression determined
by reverse transcriptase-polymerase
chain reaction (RT-PCR) representative
reactions. From left to right: mRNA
from whole cortex mRNA (Renal
Cortex), from isolated single glomerulus
(Isolated Glom), podocyte cell culture
(Cultured podocytes), un-diff.:
undifferentiated cobblestone phenotype,
diff.: differentiated arborized phenotype,
isolated single podocyte: Single
podocyte. Vascular endothelial growth
factor (VEGF) isoforms are indicated by
arrows. Note the up-regulation of VEGF
in differentiated podocytes. (B) Gene
structure of the different VEGF splice
isoforms. Arrowheads mark position of
sense and antisense RT-PCR primer [1].
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